Thorazine

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:brand
antipsychotic medication
gptkbp:actsOn adrenergic receptors
dopamine receptors
histamine receptors
muscarinic receptors
serotonin receptors
gptkbp:affiliatedWith phenothiazines
gptkbp:ATCCode N05AA01
gptkbp:CASNumber 50-53-3
gptkbp:chemicalFormula C17H19ClN2S
gptkbp:contraindication bone marrow depression
severe CNS depression
gptkbp:discoveredBy gptkb:Paul_Charpentier
gptkbp:eliminationHalfLife 30 hours
gptkbp:excretion gptkb:kidney
gptkbp:firstAntipsychotic true
gptkbp:genericName gptkb:chlorpromazine
https://www.w3.org/2000/01/rdf-schema#label Thorazine
gptkbp:introducedIn 1950
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Smith_Kline_&_French
gptkbp:metabolism liver
gptkbp:pregnancyCategory C (US)
gptkbp:routeOfAdministration oral
intramuscular
intravenous
gptkbp:sideEffect constipation
blurred vision
weight gain
drowsiness
dry mouth
extrapyramidal symptoms
neuroleptic malignant syndrome
tardive dyskinesia
gptkbp:synonym gptkb:Chlorpromazine_hydrochloride
gptkb:Hibernal
gptkb:Largactil
gptkb:Sonazine
Megaphen
gptkbp:usedFor bipolar disorder
nausea
schizophrenia
vomiting
tetanus
porphyria
psychotic disorders
severe behavioral problems in children
gptkbp:WHOModelListOfEssentialMedicines true
gptkbp:bfsParent gptkb:Smith,_Kline_&_French
gptkbp:bfsLayer 5